Overview

Repeat Dose Safety Study for Compound to Treat Anemia

Status:
Completed
Trial end date:
2009-09-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the safety and tolerability of repeat doses of compound 1278863A in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline